Selective neuronal vulnerability in Parkinson's disease

被引:45
|
作者
Gonzalez-Rodriguez, Patricia [1 ]
Zampese, Enrico [1 ]
Surmeier, D. James [1 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA
来源
关键词
Parkinson's disease; Neurodegeneration; Axon; Mitochondrial dysfunction; Oxidant stress; Calcium; alpha-synuclein; Synapse; Lewy pathology; Propagation; Aging; MITOCHONDRIAL OXIDANT STRESS; MUTANT ALPHA-SYNUCLEIN; DORSAL MOTOR NUCLEUS; DOPAMINE-CONTAINING NEURONS; SUBSTANTIA-NIGRA NEURONS; LOCUS-COERULEUS NEURONS; LEWY BODY; COMPLEX-I; PACEMAKER ACTIVITY; PEDUNCULOPONTINE NUCLEUS;
D O I
10.1016/bs.pbr.2020.02.005
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Parkinson's disease (PD) is the second most common neurodegenerative disease, disabling millions worldwide. Despite the imperative PD poses, at present, there is no cure or means of slowing progression. This gap is attributable to our incomplete understanding of the factors driving pathogenesis. Research over the past several decades suggests that both cell-autonomous and non-cell autonomous processes contribute to the neuronal dysfunction underlying PD symptoms. The thesis of this review is that an intersection of these processes governs the pattern of pathology in PD. Studies of substantia nigra pars compacta (SNc) dopaminergic neurons, whose loss is responsible for the core motor symptoms of PD, suggest that they have a combination of traits-a long, highly branched axon, autonomous activity, and elevated mitochondrial oxidant stress-that predispose them to non-cell autonomous drivers of pathogenesis, like misfolded forms of alpha-synuclein (alpha-SYN) and inflammation. The literature surrounding these issues will be briefly summarized, and the translational implications of an intersectional hypothesis of PD pathogenesis discussed.
引用
收藏
页码:61 / 89
页数:29
相关论文
共 50 条
  • [41] Neuronal pathology in Parkinson’s disease
    Jörg B. Schulz
    Björn H. Falkenburger
    Cell and Tissue Research, 2004, 318 : 135 - 147
  • [42] Neuronal xenotransplantation in Parkinson's disease
    Robin A. Weiss
    Clive Patience
    Yasuhiro Takeuchi
    Nature Medicine, 1997, 3 : 475 - 475
  • [43] Neuronal xenotransplantation in Parkinson's disease
    James M. Schumacher
    Ole Isacson
    Nature Medicine, 1997, 3 : 474 - 475
  • [44] Neuronal pathology in Parkinson’s disease
    Jörg B. Schulz
    Cell and Tissue Research, 2005, 320 (1) : 211 - 211
  • [45] Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals?
    Wong, Yvette C.
    Luk, Kelvin
    Purtell, Kerry
    Burke Nanni, Samuel
    Stoessl, A. Jon
    Trudeau, Louis-Eric
    Yue, Zhenyu
    Krainc, Dimitri
    Oertel, Wolfgang
    Obeso, Jose A.
    Volpicelli-Daley, Laura A.
    MOVEMENT DISORDERS, 2019, 34 (10) : 1406 - 1422
  • [46] Parkinson's disease, pesticides and individual vulnerability
    Paolini, M
    Sapone, A
    Gonzalez, FJ
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (03) : 124 - 129
  • [47] Physiological Phenotype and Vulnerability in Parkinson's Disease
    Surmeier, D. James
    Guzman, Jaime N.
    Sanchez, Javier
    Schumacker, Paul T.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2012, 2 (07):
  • [48] Age-related loss of calcium buffering and selective neuronal vulnerability in Alzheimer's disease
    Riascos, David
    de Leon, Dianne
    Baker-Nigh, Alaina
    Nicholas, Alexander
    Yukhananov, Rustam
    Bu, Jing
    Wu, Chuang-Kuo
    Geula, Changiz
    ACTA NEUROPATHOLOGICA, 2011, 122 (05) : 565 - 576
  • [49] An abnormal striatal synaptic plasticity may account for the selective neuronal vulnerability in Huntington's disease
    Centonze, D
    Gubellini, P
    Picconi, B
    Saulle, E
    Tolu, M
    Bonsi, P
    Giacomini, P
    Calabresi, P
    NEUROLOGICAL SCIENCES, 2001, 22 (01) : 61 - 62
  • [50] An abnormal striatal synaptic plasticity may account for the selective neuronal vulnerability in Huntington's disease
    D. Centonze
    P. Gubellini
    B. Picconi
    E. Saulle
    M. Tolu
    P. Bonsi
    P. Giacomini
    P. Calabresi
    Neurological Sciences, 2001, 22 : 61 - 62